The Potential of Scopolamine as an Antidepressant in Major Depressive Disorder: A Systematic Review of Randomized Controlled Trials

Major depressive disorder is one of the most severe mental disorders. It strongly impairs daily functioning, and, in extreme cases, it can lead to suicide. Although different treatment options are available for patients with depression, there is an ongoing search for novel therapeutic agents, such a...

Descripción completa

Detalles Bibliográficos
Autores principales: Moćko, Paweł, Śladowska, Katarzyna, Kawalec, Paweł, Babii, Yana, Pilc, Andrzej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10614934/
https://www.ncbi.nlm.nih.gov/pubmed/37893010
http://dx.doi.org/10.3390/biomedicines11102636

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10614934/
https://www.ncbi.nlm.nih.gov/pubmed/37893010
http://dx.doi.org/10.3390/biomedicines11102636

Ejemplares similares